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A b s t r a c t
Introduction: Radial or brachial access may be preferred in the case of severe peripheral artery disease (PAD) or difficult aortic 
arch anatomy during carotid artery stenting (CAS).
Aim: To evaluate the clinical conditions indicating potential benefit from non-femoral access as well as feasibility and safety of 
transradial/transbrachial access (TRA/TBA) as an alternative approach for CAS.
Material and methods: Since 2013, 67 patients (mean age: 70 years old, 44 men, 42% symptomatic) were selected for CAS 
with the TRA/TBA approach. The composite endpoint was stroke/death/myocardial infarction within 30 days of the procedure and 
compared to the propensity score matched transfemoral approach (TFA) group. Clinical (including neurological) examination and 
Doppler ultrasonography were performed before the procedure, at discharge and at 30 days.
Results: CAS with TRA/TBA was successful in 63/67 patients. Transfemoral access was not feasible due to PAD in 35 (52.2%) 
patients, bovine arch in 10 (14.9%), obesity (BMI > 35 kg/m2) in 9 (13.4%), severe degenerative disease of the spine in 7 (10.5%), 
arch type III in 5 (7.5%) and excessive subclavian stent protrusion in 1 (1.5%) patient. Mean NASCET carotid artery stenosis was 
reduced from 81% to 9% (p < 0.001). The composite endpoint occurred in 3 (4.8%) cases and it was not statistically significantly 
different from the matched TFA group (6.3%; p = 0.697). No access site complications requiring surgical intervention or blood trans-
fusion developed.
Conclusions: Transradial and transbrachial CAS may be an effective and safe procedure, and it may constitute a viable alterna-
tive to the femoral approach in patients with severe PAD, difficult aortic arch anatomy or obesity.
Key words: peripheral artery disease, carotid artery stenting, radial approach, brachial approach.
S u m m a r y
The femoral artery is the conventional approach for carotid artery stenting (CAS). However, in cases of anatomy variant of 
the aortic arch and supra-aortic vessels, significant peripheral artery disease or severe obesity, radial or brachial access may 
be preferred. We found that in these cases transradial and transbrachial CAS may be an effective and safe procedure, and it 
may constitute a viable alternative to the femoral approach.
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Introduction
Carotid artery disease is one of the main causes of 
ischemic stroke and, as a consequence, severe disability 
in adults [1]. Percutaneous carotid artery stenting (CAS) 
has become a viable alternative for carotid endarterecto-
my, particularly in ageing populations with multiple co-
morbidities and high perioperative risk [2, 3].
The femoral artery is the conventional approach for 
CAS procedures. However, anatomical variants of the 
aortic arch and supra-aortic vessels or significant pe-
ripheral vascular disease can make catheterization of 
the common carotid artery difficult or even impossible 
[4]. In these cases with a  challenging aortic arch, the 
transfemoral approach can lead to prolonged catheter 
manipulation increasing the perioperative risk of neuro-
logical ischemic complications. Furthermore, access site 
complications as well as contraindications for prolonged 
bed rest may necessitate an alternative access. Thus, the 
increasingly used transradial approach for coronary inter-
ventions has also been evaluated as an alternative strat-
egy for carotid artery stenting. Carotid artery stenting via 
the radial/brachial artery is more demanding owing to 
the need for dedicated systems and techniques. More-
over, operator volume and learning curve are important 
determinants of technical success and periprocedural 
outcomes.
Aim
The aim of the study was to evaluate the clinical con-
ditions indicating potential benefit from non-femoral ac-
cess as well as feasibility and safety of TRA/TBA as an 
alternative approach for CAS.
Material and methods
From June 2013 among 2253 CAS procedures, 67 (3%) 
patients were selected to undergo TRA/TBA – CAS. The 
indications for the non-femoral approach were based 
on our own experiences and literature review [5–7]. The 
grade of carotid stenosis and anatomy of the aortic arch 
were determined by use of preoperative duplex ultraso-
nography (DUS) and/or computed tomographic angiog-
raphy (CTA), and verified by intraoperative angiography. 
Carotid stenting was performed in asymptomatic pa-
tients who had carotid artery stenosis ≥ 70% by arte-
riography and in symptomatic patients (TIAs or strokes 
occurring within 6 months prior to CAS) with ≥ 50% ste-
nosis, according to NASCET (North American Symptomat-
ic Carotid Endarterectomy Trial) criteria [8, 9]. All patients 
underwent examination by the site neurologist and all 
provided informed consent before any intervention. This 
study was approved by the Committee on Research Eth-
ics at our hospital, in compliance with the ethical guide-
lines of the Declaration of Helsinki. The patients had 
been treated protractedly with aspirin (75 mg/day) and 
prior to the procedure received a 300 mg loading dose of 
clopidogrel. After CAS the aspirin was maintained indef-
initely and 75 mg/day of clopidogrel was continued for 
3 months.
An Allen’s test was performed in each patient be-
fore the transradial approach. On the procedure day, the 
right radial or brachial artery was punctured and a 7 Fr 
Glidesheath Slender (Terumo) was introduced. After the 
artery cannulation, heparin was given to achieve an ac-
tivated coagulation time of 250–300 s. Subsequently, 
Cobra I  & II or Sidewinder diagnostic catheters (Teru-
mo, Cordis) were used and in all cases over a 0.035-inch 
diagnostic wire a  7 Fr Guider Softip (Boston Scientific) 
guiding catheter was introduced to the common carotid 
artery. All CAS procedures were neuroprotected. Direct 
stenting was performed when possible. Before and after 
CAS, the degree of stenosis was calculated with quanti-
tative angiography (Figure 1). Technical success was de-
fined as successful revascularization with residual steno-
sis ≤ 30% by NASCET criteria. The primary endpoint was 
the composite of stroke, death and myocardial infarction 
within 30 days of the procedure. Technical failure was 
identified when the procedure was abandoned and the 
cause was noted. 
Among 1237 completed TFA CAS we performed pro-
pensity score matching with TRA/TBA CAS at a 1 : 1 ratio 
using the following variables: (i) age, (ii) sex, (iii) clinical 
presentation, (iv) comorbidities, (v) percentage of carotid 
artery stenosis, and (vi) contralateral carotid occlusion. 
Patients after contralateral CAS and re-CAS or procedures 
using proximal embolic protection devices were excluded 
from the TFA group.
Clinical (including neurological) examination and DUS 
were performed in all patients before the procedure, at 
discharge and at 30 days of follow-up.
Statistical analysis
Continuous data were presented as means ± stan-
dard deviation; categorical data were given as counts 
(percentages). Normality of distribution was assessed 
by the Kolmogorov-Smirnov test. A  propensity score 
matching technique was used to balance available base-
line covariates. Fisher’ s exact test or χ2 test was used 
to analyze categorical variables and Student’ s t-test or 
Mann-Whitney U-test for continuous variables. A p-value 
of < 0.05 was considered as statistically significant. All 
analyses were evaluated in Statistica 9.0 (StatSoft Inc) or 
SPSS 23.0 (SPSS Inc., Chicago, Illinois, USA).
Results
The mean age of the treated patients (44 men) 
was 70 years (range: 51–88 years), and 28 (41.8%) pa-
tients were symptomatic (TIA or stroke occurring within 
6 months prior to CAS). Transfemoral access was not fea-
sible due to peripheral artery disease (PAD) in 35 (52.2%) 
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patients – the most common causes were Leriche syn-
drome or history of aorto/femoro-femoral bypass im-
plantation. The bovine arch (the left common carotid 
artery arises from brachiocephalic trunk) was the reason 
for a radial approach in 10 (14.9%) cases. Nine (13.4%) 
patients were disqualified from TFA CAS due to obesity 
with a body mass index over 35 and 7 (10.5%) due to 
severe degenerative disease of the spine (inability to un-
dergo femoral arterial puncture and/or lie down during/
after procedure). Moreover, type III aortic arch (all three 
supra-aortic vessels arise before and below the top of the 
aortic arch) were described in 5 (7.5%) cases. In 1 (1.5%) 
patient, CAS was performed via the radial artery due to 
excessive protrusion of the stent into the aortic arch af-
ter left subclavian artery stenting in the past (Figure 2). 
Brachial access was used in 3 cases due to an unsuc-
cessful radial artery puncture attempt and in one case of 
radial artery occlusion. Baseline demographic and clinical 
Figure 1. A – Left internal carotid artery stenosis (large arrow). TBC – truncus brachiocephalicus and bovine 
arch (thin arrow). B – Selective angiography confirming critical stenosis of the left internal carotid artery.  
C – Self-expanding Carotid Wallstent (Boston Scientific) 7 mm × 30 mm delivery (white arrow). D – Ultra Soft 
(Boston Scientific) 5.0 mm × 20 mm balloon post-dilatation. E – Final angiography of carotid stenting
D E
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characteristics, indication for CAS and propensity score 
matching with the TFA group are listed in Table I.
We were able to successfully complete the CAS pro-
cedure using transradial/transbrachial access in 63 of 
67 patients (94% technical success rate). Procedural fail-
ure was due to unsuccessful distal embolic protection 
device delivery, massive carotid artery calcification and 
subclavian artery tortuosity in 2 cases. In 2 of these 4 pa- 
tients the procedure was completed through a  direct 
transcervical approach without complications (the punc-
ture sites were closed with sutures). The other 2 patients 
were qualified for high-risk carotid endarterectomy (both 
were uneventful). The mean NASCET carotid artery steno-
sis was reduced from 81% to 9% (p < 0.001). Direct stent 
implantation was performed in 30 (47.6%) cases. Among 
63 completed TRA/TBA CAS, technical success was 
achieved in 61 (97%) patients. In 2 patients 35–40% re-
sidual stenosis remained without peri- and postprocedur-
al complications. Procedural data are shown in Table II.
The composite endpoint occurred in 3 (4.8%) cases. 
These patients were disqualified from TFA CAS due to 
PAD, degenerative disease of the spine and severe obe-
sity. One patient died as a result of an intracranial hem-
orrhage that occurred 2 days after the procedure. Two 
Figure 2. A – Excessive protrusion of subclavian stent into the aortic arch (black arrow). B – Successful cannu-
lation of the right common carotid artery with 7 Fr Guider Softip (Boston Scientific) guiding catheter via the 
right radial artery. C – Selective angiography confirming critical stenosis of the right internal carotid artery. 
D – Self-expanding Precise (Cordis) 8 mm × 30 mm post-dilatation with 5.0 mm × 20 mm balloon. E – Final 
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patients sustained a  major ischemic stroke during the 
first postprocedural day. Both subsequently improved 
substantially over the next few weeks. There was no sig-
nificant difference in complication rate between bovine 
arch, type III aortic arch, obesity, degenerative disease of 
the spine and PAD subgroups.
No radial or brachial access site complications requir-
ing surgical intervention or blood transfusion developed. 
Although radial artery patency assessment was not per-
formed after the procedure, no hand ischemia symptoms 
occurred. Neither TIA nor myocardial infarction occurred.
In the matched TFA group, the composite endpoints 
occurred in 4 (6.3%) cases – 2 major ischemic strokes 
and 2 TIAs. No statistically significant differences were 
observed in the overall endpoints (4.8% vs. 6.3%; 
p = 0.697), major stroke (3.2% vs. 3.2%; p = 1.000), TIA 
(0% vs. 3.2%; p = 0.154) or death (1.6% vs. 0%; p = 0.315) 
between TRA/TBA and the matched TFA groups.
Table I. Patient baseline characteristics and indications for radial/brachial access (n = 67). Propensity score 
matching between TRA/TBA and TFA CAS at 1 : 1 ratio 
Parameter Value
Demography and comorbidities:
Age [years] 70 ±8.6
Gender, men 44 (65.7)
Stroke/TIA 28 (41.8)
Hypertension 66 (98.5)
Diabetes mellitus 21 (31.3)
Dyslipidaemia 66 (98.5)
Coronary artery disease 43 (64.2)
Previous percutaneous intervention coronary 24 (35.8)
Previous myocardial infarction 16 (23.9)
History of coronary artery bypass grafting 9 (13.4)
Indication for radial/brachial access:
Severe peripheral artery disease 35 (52.2)
Bovine arch 10 (14.9)
Obesity, BMI > 35 kg/m2 9 (13.4)
Severe degenerative disease of the spine 7 (10.5)
Type III aortic arch 5 (7.5)
Excessive protrusion of the subclavian stent into the aortic arch 1 (1.5)
Propensity score matching
Parameter TRA/TBA (n = 63) TFA (n = 63) P-value
Age [years] 69.8 ±8.7 69.2 ±8.6 0.687
Gender, men 41 (65.1) 43 (68.3) 0.705
Stroke/TIA 26 (41.3) 25 (39.7) 0.856
Diabetes mellitus 19 (30.2) 23 (36.5) 0.450
Previous percutaneous intervention coronary 23 (36.5) 25 (39.7) 0.714
Previous myocardial infarction 15 (23.8) 15 (23.8) 1.000
History of coronary artery bypass grafting 9 (14.3) 8 (12.7) 0.794
Contralateral carotid occlusion 11 (17.5) 10 (15.9) 0.811
Percentage of carotid artery stenosis 81.5 ±8.2 81.7 ±8.1 0.744
Values are mean ± SD or n (%).
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Discussion
The transfemoral approach (TFA) is the most com-
mon access for carotid angiography and carotid artery 
stenting as the majority of operators are familiar with 
this technique, it accepts the use of large diameter in-
troducers (typically 9F for a  proximal neuroprotection 
device) and is associated with a high technical success 
rate [10, 11]. Despite these advantages, the femoral ap-
proach has many limitations including problematic ca-
rotid cannulation in patients with a  type III aortic arch 
or with a bovine arch. As reported by Nagarra et al., un-
favorable aortic arch anatomy was an independent risk 
factor of periprocedural complication of CAS [12]. Fagg-
ioli et al. suggested that during transfemoral CAS, silent 
cerebral embolization (assessed with diffusion-weighted 
MR) is related not only to the stenting procedure but also 
to aortic arch catheter maneuvering – 58% patients had 
signs of ischemia in both hemispheres [13]. Therefore, 
the transradial approach may reduce catheter-induced 
embolization from the aortic arch by the avoidance of 
catheter manipulation [14]. 
Obesity, a well-known major public health issue, is an 
independent risk factor for cardiovascular disease (CVD) 
and one of the main causes of the increased risk of poly-
vascular atherosclerosis [15]. Ahmed’s meta-analysis re-
ported the prevalence of asymptomatic carotid stenosis 
> 70% in patients with lower extremity artery disease 
(LEAD) at 14% [16]. Moreover, in Aboyans’s study, carot-
id disease appears to be twice as common among LEAD 
patients as among coronary artery disease patients [17]. 
Both obesity and LEAD are associated with more access 
site and bleeding complications after TFA interventions. 
Thus, in cases of severe obesity, aortoiliac disease or un-
favorable aortic arch anatomy transradial access (TRA) 
remains a viable alternative. TRA was first introduced by 
invasive cardiologists and has become the first coronary 
access line due to the lower vascular/systemic compli-
cation rate and number of major bleeding events. In ad-
dition, fast mobilization after the TRA procedure results 
in increased comfort and shortens hospitalization time 
[18, 19]. Thus, TRA has also been proposed for the treat-
ment of supra-aortic vessels, including extracranial ca-
rotid arteries [5, 20]. Compared with transradial coronary 
interventions, CAS via the radial/brachial artery is more 
challenging due to the need for use of dedicated systems 
and techniques, and it demands the highest level of ex-
perience from operators. Furthermore, the small size of 
the radial artery may exclude the use of large-diameter 
devices (> 7F), including proximal embolic protection sys-
tems.
Carotid artery stenting by the TRA/TBA may be per-
formed using the contralateral or the ipsilateral radial 
artery. However, the right TRA/TBA may be the preferred 
strategy for cannulation of the right common carotid ar-
tery (CCA) or the left CCA, especially in the presence of 
a bovine arch. The advantage of the right radial/brachial 
approach is an adequate support (even at acute angles 
of the common carotid artery origin) and lower radiation 
exposure. TRA for non-bovine left internal carotid disease 
is more challenging due to the unfavorable origin angle 
resulting in insufficient support for the catheter system 
[21]. Keeping in mind all the above, we concluded that 
with optimal selection of cases, right radial/brachial ar-
tery access CAS may by successful in all cases.
The well-known benefits of radial access CAS are 
fewer vascular access complications and major bleeding 
events when compared with the femoral approach, es-
pecially in the older population [6]. Despite the fact that 
TBA has been shown to be associated with relatively high 
risk of vascular complications [22], in our study no ac-
cess-site complications requiring surgical intervention or 
blood transfusion occurred.
Cerebral hyperperfusion syndrome (CHS) after carot-
id artery revascularization is a rare (< 1%) but potentially 
devastating complication of CAS leading to an intracra-
nial hemorrhage (ICH) and death in up to 50% of cas-
es [23–25]. Preoperative risk factors for development 
Table II. Procedural data (n = 67)
Parameter Value
Right carotid artery 39 (58.2%)
Left carotid artery 28 (41.8%)
Contralateral occlusion 11 (16.4%)
Technical success rate by radial/brachial access: 63
Transradial access 59
Transbrachial access 4
Direct stenting 30 (47.6%)




Carotid Wallstent (Boston Scientific) 33 (52.3%)
Roadsaver (Terumo) 18 (28.6%)
Cristallo Idealle (Medtronic) 6 (9.5%)
Precise (Cordis) 3 (4.8%)
Mer (Balton) 3 (4.8%)
Neuroprotection type:
Spider FX (Medtronic) 29 (46%)
FilterWire EZ (Boston Scientific) 19 (30.2%)
Wirion (Allium Medical) 9 (14.3%)
Emboshield (Abbott) 6 (9.5%)
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of CHS/ICH include long standing hypertension, diabetes 
mellitus, advanced age, recent procedure on contralater-
al vessel (< 3 months), high degree of stenosis with poor 
collateral flow, severe contralateral carotid occlusion, re-
cent stroke and/or ischemia or incomplete circle of Willis 
[26]. In our study, the patient who died as a result of an 
intracranial hemorrhage had many of the above risk fac-
tors – long-standing hypertension with severe obesity 
(BMI > 35 kg/m2), diabetes mellitus, recent stroke and 
90% stenosis of the carotid artery with contralateral oc-
clusion. In our case, ICH occurred 2 days after the proce-
dure and it is consistent with the data showing that the 
average time from the CAS procedure to development 
of CHS was 12 h and no cases of CHS were described 
after 6 days [27]. The current practice is to discharge 
patients within 24–48 h of CAS; therefore they should 
be aware of the possibility of developing CHS after re-
turning home.
Khan et al. identified multiple risk factors (clinical, 
institutional, angiographic and procedural) for stroke, 
death, and myocardial infarction (MI) within 1 month in 
patients undergoing carotid artery stent placement [28]. 
Distal embolization is the major neurological complica-
tion occurring after CAS, is not only limited to the proce-
dural time and may occur at any stage of the procedure 
(including introduction/retrieval of the guiding catheter) 
[29, 30]. The use of novel, mesh-covered stents has re-
vealed an important role of exclusion of atherosclerotic 
plaque from the circulation [31, 32], but their use does 
not guarantee full anti-embolic protection during CAS. In 
our group, two major ischemic strokes occurred within 
a  few hours after CAS. Both patients had angiograph-
ic and clinical risk factors for peri- and postprocedural 
stroke (symptomatic status, diabetes mellitus, chronic 
kidney failure). Despite usage of a closed-cell designed 
stent (Roadsaver (Terumo) and Carotid Wallstent (Boston 
Scientific)) it was impossible to avoid neurological em-
bolic complications in those patients. 
The percentage of endpoints in TRA/TBA and the 
matched TFA groups was similar without statistically sig-
nificant differences. It shows that despite the additional 
factors disqualifying from the femoral approach, TRA/
TBA may constitute a viable alternative in these high-risk 
patients.
There are several important limitations of the study. 
First, this is a nonrandomized, retrospective observation-
al registry involving a  small group of selected patients. 
The second limitation is that microembolization was not 
assessed with imaging tests, and thus silent cerebral 
ischemia might have been overlooked. 
Conclusions
Transradial and transbrachial CAS may be an effective 
and safe procedure, and it may constitute a viable alter-
native to the femoral approach in patients with severe 
peripheral artery disease, difficult aortic arch anatomy or 
obesity.
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